BNP Paribas Asset Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.7K Sell
1,309
-591
-31% -$15.2K ﹤0.01% 1850
2026
Q1
$44.4K Buy
1,900
+455
+31% +$8.24K ﹤0.01% 1787
2025
Q4
$21K Buy
1,445
+404
+39% +$7.64K ﹤0.01% 1936
2025
Q3
$26K Buy
1,041
+32
+3% +$714 ﹤0.01% 1285
2025
Q2
$23K Buy
+1,009
New +$23.9K ﹤0.01% 1439
2017
Q1
– Sell
-215,015
Closed -$7.12M – 973
2016
Q4
$7.12M Buy
+215,015
New +$8.34M 0.07% 391

Other funds holding ACHC

BNP Paribas Asset Management's ACHC Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Acadia Healthcare (ACHC) stake by 31% in Q2 2026, selling an estimated $15.2K and leaving 1,309 shares worth $38.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1850.

BNP Paribas Asset Management first reported a position in ACHC in Q4 2016 and has held it in 6 quarters since. The position peaked at $7.12M in Q4 2016. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • BNP Paribas Asset Management held 1,309 shares of Acadia Healthcare worth $38.7K as of Q2 2026.
  • BNP Paribas Asset Management sold 591 Acadia Healthcare shares in Q2 2026, an estimated $15.2K.
  • Acadia Healthcare made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1850 holding.
  • BNP Paribas Asset Management first reported a position in Acadia Healthcare in Q4 2016 and has held it in 6 quarters since.
  • BNP Paribas Asset Management's Acadia Healthcare position peaked at $7.12M in Q4 2016.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.